Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online March 14, 2007
Diabetes 56:1647-1654, 2007
DOI: 10.2337/db07-0123
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-0123v1
56/6/1647    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Yu, Y.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Yu, Y.-H.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Increasing Dietary Leucine Intake Reduces Diet-Induced Obesity and Improves Glucose and Cholesterol Metabolism in Mice via Multimechanisms

Yiying Zhang1,2, Kaiying Guo1, Robert E. LeBlanc1, Daniella Loh1, Gary J. Schwartz3, and Yi-Hao Yu4

1 Department of Pediatrics, Division of Molecular Genetics, Columbia University, New York, New York
2 Naomi Berrie Diabetes Center, Columbia University, New York, New York
3 Department of Medicine and Neuroscience, Diabetes Research and Training Center, Albert Einstein College of Medicine, Bronx, New York
4 Department of Medicine, Division of Preventive Medicine, Columbia University, New York, New York

Address correspondence and reprint requests to Yiying Zhang, PhD, Division of Molecular Genetics, Department of Pediatrics, Columbia University, Russ Berrie Pavilion, Rm. 620, 1150 St. Nicholas Ave., New York, NY 10032. E-mail: yz84{at}columbia.edu. Or Yi-Hao Yu, MD, PhD, Division of Preventive Medicine, Department of Medicine, Columbia University, 630 W. 168th St., PH 10-305J, New York, NY 10032. E-mail: yy102{at}columbia.edu

Abbreviations: BAT, brown adipose tissue; G6P, glucose-6-phosphatase; HFD, high-fat diet; HOMA-IR, homeostasis model assessment of insulin resistance; mTOR, mammalian target of rapamycin; UCP, uncoupling protein; WAT, white adipose tissue

Leucine, as an essential amino acid and activator of mTOR (mammalian target of rapamycin), promotes protein synthesis and suppresses protein catabolism. However, the effect of leucine on overall glucose and energy metabolism remains unclear, and whether leucine has beneficial effects as a long-term dietary supplement has not been examined. In the present study, we doubled dietary leucine intake via leucine-containing drinking water in mice with free excess to either a rodent chow or a high-fat diet (HFD). While it produced no major metabolic effects in chow-fed mice, increasing leucine intake resulted in up to 32% reduction of weight gain (P < 0.05) and a 25% decrease in adiposity (P < 0.01) in HFD-fed mice. The reduction of adiposity resulted from increased resting energy expenditure associated with increased expression of uncoupling protein 3 in brown and white adipose tissues and in skeletal muscle, while food intake was not decreased. Increasing leucine intake also prevented HFD-induced hyperglycemia, which was associated with improved insulin sensitivity, decreased plasma concentrations of glucagon and glucogenic amino acids, and downregulation of hepatic glucose-6-phosphatase. Additionally, plasma levels of total and LDL cholesterol were decreased by 27% (P < 0.001) and 53% (P < 0.001), respectively, in leucine supplemented HFD-fed mice compared with the control mice fed the same diet. The reduction in cholesterol levels was largely independent of leucine-induced changes in adiposity. In conclusion, increases in dietary leucine intake substantially decrease diet-induced obesity, hyperglycemia, and hypercholesterolemia in mice with ad libitum consumption of HFD likely via multiple mechanisms.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.